Adcock Ingram 

ZAC7,480
7
+ZAC10+0.13% Tuesday 15:00

Statistics

Day High
7,489
Day Low
7,470
52W High
7,489
52W Low
4,301
Volume
719,869
Avg. Volume
187,477
Mkt Cap
0
P/E Ratio
10.37
Dividend Yield
3.74%
Dividend
280

Upcoming

Dividends

3.74%Dividend Yield
Mar 26
ZAC115
Sep 25
ZAC165
Mar 25
ZAC115
Sep 24
ZAC150
Mar 24
ZAC125
10Y Growth
13.21%
5Y Growth
22.87%
3Y Growth
9.55%
1Y Growth
1.82%

Earnings

25FebExpected
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q4 2024
Q2 2025
Q4 2025
0
0.05
0.1
0.15
Expected EPS
N/A
Actual EPS
N/A

Financials

8.62%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
1.45TRevenue
124.82BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AIP.JO. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson is a global healthcare company that competes with Adcock Ingram in various segments including pharmaceuticals and consumer health products.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global biopharmaceutical company that competes directly with Adcock Ingram in the pharmaceuticals sector, particularly in the development and marketing of medications.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that competes with Adcock Ingram in the pharmaceuticals and generics sectors, offering a wide range of healthcare products.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline is a global healthcare company that competes with Adcock Ingram in pharmaceuticals, vaccines, and consumer healthcare products.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. is a global healthcare company that competes with Adcock Ingram in the pharmaceuticals sector, particularly in the development of innovative medicines.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie is a global biopharmaceutical company that competes with Adcock Ingram in the development and marketing of pharmaceutical products.
Sanofi
SNY
Mkt Cap124.45B
Sanofi is a global healthcare company that competes with Adcock Ingram in the pharmaceuticals and vaccines sectors, offering a broad range of healthcare solutions.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb is a global biopharmaceutical company that competes with Adcock Ingram in the development and distribution of prescription pharmaceuticals.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company that competes with Adcock Ingram in the generics and specialty medicines sectors.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca is a global biopharmaceutical company that competes with Adcock Ingram in the development and commercialization of prescription medicines, particularly in the oncology, cardiovascular, renal & metabolism, and respiratory sectors.

About

Adcock Ingram Holdings Limited manufactures, markets, and distributes healthcare products in South Africa, the United States, Canada, the United Kingdom, rest of Europe, and internationally. It offers a portfolio of over-the-counter products, prescription medicines, and consumer products, as well as instrumentation and surgical products. The company also provides a range of pharmaceutical products, such as women's health, cannabidiol oil, antiretroviral, dermatology, central nervous system, respiratory, ophthalmology, generics, cardiovascular, pain, gastroenterology, energy supplements, colds and flu, personal care, feminine hygiene, digestive well-being, allergies, baby care, cough, food and nutrition supplements, vitamins, and minerals supplements. In addition, it manufactures and supplies hospital and critical care products, including intravenous solutions, renal dialysis systems, and blood collection products. The company serves private and public sectors. Adcock Ingram Holdings Limited was founded in 1890 and is headquartered in Midrand, South Africa.
Show more...
CEO
Mr. Andrew Gideon Hall CA (SA), BPharm
Country
South Africa
ISIN
ZAE000123436

Listings

0 Comments

Share your thoughts

FAQ

What is Adcock Ingram stock price today?
The current price of AIP.JO is ZAC7,480 ZAC — it has increased by +0.13% in the past 24 hours. Watch Adcock Ingram stock price performance more closely on the chart.
What is Adcock Ingram stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Adcock Ingram stocks are traded under the ticker AIP.JO.
Is Adcock Ingram stock price growing?
AIP.JO stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Adcock Ingram has showed a +48.12% increase.
What is Adcock Ingram revenue for the last year?
Adcock Ingram revenue for the last year amounts to 1.45T ZAC.
What is Adcock Ingram net income for the last year?
AIP.JO net income for the last year is 124.82B ZAC.
Does Adcock Ingram pay dividends?
Yes, AIP.JO dividends are paid semi-annual. The last dividend per share was 115 ZAC. As of today, Dividend Yield (FWD)% is 3.74%.
In which sector is Adcock Ingram located?
Adcock Ingram operates in the Healthcare sector.
When did Adcock Ingram complete a stock split?
Adcock Ingram has not had any recent stock splits.
Where is Adcock Ingram headquartered?
Adcock Ingram is headquartered in Midrand, South Africa.